Phosphodiesterases are drug targets for treating various diseases. Inhibition of these can increase cAMP and cGMP levels, which can affect a variety of physiological responses. Here we report a new method for determining PDE activity by combining high-performance liquid chromatography and tandem mass spectrometry. Characteristic peaks of the substrates, cGMP or cAMP and products, GMP or AMP, were identified in positive-ion electrospray ionization using multiple reaction monitoring. The method can be applied to determine activity of PDE inhibitors. Our results showed that this new method was fast, sensitive and highly reproducible. (C) 2007 Elsevier B.V. All rights reserved.8591374
Chronic activation of β-adrenergic (β-AR) pathway causes excessive accumulation of cAMP in cardiomyo...
Cardiovascular diseases are the number one death worldwide. Nitric oxide (NO)-NO-sensitive (soluble)...
Cyclic nucleotide phosphodiesterases (PDEs) catalyse the hydrolysis of cyclic AMP and cyclic GMP, th...
Phosphodiesterases are drug targets for treating various diseases. Inhibition of these can increase ...
A simple, quick, easy and cheap tandem mass spectrometry (MS/MS) method for the determination of ade...
The cyclic nucleotide phosphodiesterases (PDEs) are intracellular enzymes that catalyze the hydrolys...
Extraction of frozen canine cardiac muscle rendered soluble over 90% of the cyclic AMP phosphodieste...
The ability to rapidly identify active compounds in a complex mixture (e.g., natural products extrac...
As second messengers, the cyclic purine nucleotides adenosine 3',5'-cyclic monophosphate (cAMP) and ...
Neben den cAMP- und cGMP-abhängigen Proteinkinasen (PKA bzw. PKG) sind als zyklonukleotid-regulierte...
The ability to rapidly identify active compounds in a complex mixture (e.g., natural products extrac...
A new assay for cyclic nucleotide phosphodiesterase has been developed by using reverse-phase column...
AbstractPhosphodiesterases (PDEs) capable of degrading cAMP and cGMP are indispensable for the regul...
Cyclic nucleotide derivatives have been used as a tool to investigate the existence of distinctive a...
<p>BF066 concentration-dependently inhibited activity of PDE extracted from human platelets. A) Repr...
Chronic activation of β-adrenergic (β-AR) pathway causes excessive accumulation of cAMP in cardiomyo...
Cardiovascular diseases are the number one death worldwide. Nitric oxide (NO)-NO-sensitive (soluble)...
Cyclic nucleotide phosphodiesterases (PDEs) catalyse the hydrolysis of cyclic AMP and cyclic GMP, th...
Phosphodiesterases are drug targets for treating various diseases. Inhibition of these can increase ...
A simple, quick, easy and cheap tandem mass spectrometry (MS/MS) method for the determination of ade...
The cyclic nucleotide phosphodiesterases (PDEs) are intracellular enzymes that catalyze the hydrolys...
Extraction of frozen canine cardiac muscle rendered soluble over 90% of the cyclic AMP phosphodieste...
The ability to rapidly identify active compounds in a complex mixture (e.g., natural products extrac...
As second messengers, the cyclic purine nucleotides adenosine 3',5'-cyclic monophosphate (cAMP) and ...
Neben den cAMP- und cGMP-abhängigen Proteinkinasen (PKA bzw. PKG) sind als zyklonukleotid-regulierte...
The ability to rapidly identify active compounds in a complex mixture (e.g., natural products extrac...
A new assay for cyclic nucleotide phosphodiesterase has been developed by using reverse-phase column...
AbstractPhosphodiesterases (PDEs) capable of degrading cAMP and cGMP are indispensable for the regul...
Cyclic nucleotide derivatives have been used as a tool to investigate the existence of distinctive a...
<p>BF066 concentration-dependently inhibited activity of PDE extracted from human platelets. A) Repr...
Chronic activation of β-adrenergic (β-AR) pathway causes excessive accumulation of cAMP in cardiomyo...
Cardiovascular diseases are the number one death worldwide. Nitric oxide (NO)-NO-sensitive (soluble)...
Cyclic nucleotide phosphodiesterases (PDEs) catalyse the hydrolysis of cyclic AMP and cyclic GMP, th...